Virtual Music Therapy for Alzheimer's Disease
Trial Summary
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Virtual Music Therapy for Alzheimer's Disease?
Research shows that music therapy can improve feelings, emotions, and social engagement in people with Alzheimer's, and it may also reduce stress and improve mood. Studies suggest that music therapy is usable and enjoyable for Alzheimer's patients, fostering positive interactions and reminiscence.12345
Is virtual music therapy safe for humans?
How is Virtual Music Therapy different from other treatments for Alzheimer's disease?
Virtual Music Therapy is unique because it leverages music's ability to stimulate cognitive functions and improve mood, while being delivered through a virtual platform that allows personalized music selection and interaction. This approach can enhance memory recall and emotional well-being without relying on medication, making it a promising non-drug intervention for Alzheimer's patients.478910
What is the purpose of this trial?
This study is designed to assess the feasibility that individualized reminiscence-based virtual music therapy sessions can enhance autobiographical memory, mood, and cognition in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD).60 patients with MCI or mild dementia due to AD will receive two 30 minutes reminiscence-targeted virtual music therapy interventions per week for 8 weeks (a total of 16 sessions).Participants' (or supported by the study partner) self-reported and measurable outcomes including cognitive, anxiety, quality of life, and autobiographical memory will be assessed before and after the 8-week course of treatment. Blood-oxygenation level-dependent (BOLD) in functional magnetic resonance imaging (fMRI) will also be also measured before and after the 8-week course of treatment.
Research Team
Alexander Pantelyat, MD
Principal Investigator
Department of Neurology, Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for adults aged 18-89 with mild cognitive impairment or early Alzheimer's Disease, as indicated by specific scores on a cognitive assessment test (MoCA). It excludes those who've had significant head trauma, are claustrophobic to the extent that they can't undergo MRI scans, have medical devices or metal in their body that interfere with MRI technology.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive reminiscence-targeted virtual music therapy sessions twice a week for 8 weeks
Follow-up
Participants are monitored for changes in cognitive, anxiety, quality of life, and autobiographical memory levels, as well as brain activation patterns using fMRI
Treatment Details
Interventions
- Virtual Music Therapy
Virtual Music Therapy is already approved in United States, European Union, China, Japan for the following indications:
- Alzheimer's Disease
- Mild Cognitive Impairment
- Alzheimer's Disease
- Dementia
- Alzheimer's Disease
- Cognitive Impairment
- Alzheimer's Disease
- Dementia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor